UnknownNCT05025956
Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
PHASE1 · PHASE2 · 68 planned enrolment
- Countries listed
- 1
- Registry update
- April 16, 2024
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
44 matching trial registrations
- Intervention Placebo
Showing 31–44 of 44. Every record below meets all the filters shown above.
CompletedNCT04488601
Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study
PHASE2 · 129 planned enrolment
- Countries listed
- 1
- Registry update
- January 24, 2024
CompletedNCT02986659
Genomic Outcomes of Metformin
PHASE4 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- November 18, 2023
CompletedNCT03772964
Effects of Metformin in a Non-Diabetic Patient Population
PHASE1 · PHASE2 · 32 planned enrolment
- Countries listed
- 1
- Registry update
- January 11, 2023
TerminatedNCT01842399
Resveratrol and Cardiovascular Health in the Elderly
PHASE1 · PHASE2 · 73 planned enrolment
- Countries listed
- 1
- Registry update
- December 23, 2022
TerminatedNCT03451006
Effect of Metformin on Frailty in 12 Subjects
PHASE2 · 7 planned enrolment
- Countries listed
- 1
- Registry update
- November 17, 2022
CompletedNCT01375959
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
Phase not reported · 38 planned enrolment
- Countries listed
- 1
- Registry update
- October 26, 2022
CompletedNCT01808690
EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes
PHASE3 · 52 planned enrolment
- Countries listed
- 1
- Registry update
- September 30, 2021
CompletedNCT01914133
Acarbose and Older Adults With Postprandial Hypotension
PHASE2 · 42 planned enrolment
- Countries listed
- 1
- Registry update
- May 28, 2021
CompletedNCT02432287
Metformin in Longevity Study (MILES).
PHASE4 · 16 planned enrolment
- Countries listed
- 1
- Registry update
- May 21, 2021
CompletedNCT00620191
Metformin in Amnestic Mild Cognitive Impairment
PHASE2 · 80 planned enrolment
- Countries listed
- 1
- Registry update
- October 23, 2020
CompletedNCT02874924
Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly
PHASE2 · 34 planned enrolment
- Countries listed
- 1
- Registry update
- December 4, 2018
CompletedNCT02246660
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
Phase not reported · 66 planned enrolment
- Countries listed
- 1
- Registry update
- April 30, 2018
CompletedNCT01765946
Metformin and Longevity Genes in Prediabetes
PHASE4 · 38 planned enrolment
- Countries listed
- 1
- Registry update
- March 13, 2013